|
ABCIXIMAB c7E3 FAB |
QJ MED 95:635-638 |
2002 |
55 YRS |
M |
No |
Yes |
1 |
3 |
NA |
|
ABCIXIMAB
c7E3 FAB |
J CARDIOVASC
PHARMACOL THERAPEUT 7:21-24 |
2002 |
65 YRS |
F |
No |
Yes |
1 |
2 |
NA |
|
ABCIXIMAB c7E3 FAB |
HEART 86:E18 |
2001 |
68 YRS |
M |
YES |
No |
2 |
4 |
NA |
|
ABCIXIMAB c7E3 FAB |
HEART 83:E5 |
2000 |
64 YRS |
M |
NO |
Yes |
0 |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
NZ MED J 113:86 |
2000 |
56 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
ANN PHARMACOTHER
34:924 |
2000 |
71 YRS |
m |
NA |
No |
NA |
4 |
NA |
|
ABCIXIMAB c7E3 FAB |
J INVASIVE CARDIOL
12:528 |
2000 |
80 YRS |
F |
NO |
Yes |
0 |
2 |
NA |
|
ABCIXIMAB c7E3 FAB |
CARDIOLOGY 95:215-216 |
2001 |
55 YRS |
M |
NA |
No |
NA |
4 |
NA |
|
ABCIXIMAB c7E3 FAB |
CATHET CARDIOVASC
INTERV 49:177-180 |
2000 |
56 YRS |
F |
YES |
Yes |
3 |
4 |
NA |
|
ABCIXIMAB c7E3 FAB |
J INVASIVE CARDIOL
13:56 |
2001 |
52 YRS |
F |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
CATHET CARDIOVASC
INTERV 52:468 |
2001 |
75 YRS |
F |
NO |
Yes |
0 |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL 85:435 |
2000 |
NA |
NA |
NA |
No |
|
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL 85:435 |
2000 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL 85:435 |
2000 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL 85:435 |
2000 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL 85:435 |
2000 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL 85:435 |
2000 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
NEJM 344:1888-1894 |
2001 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ABCIXIMAB c7E3 FAB |
AM HEART J 140:74 |
2000 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ABCIXIMAB c7E3 FAB |
CARDIOLOGY 95:215-216 |
2001 |
51 YRS |
M |
NA |
No |
NA |
4 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J HEMATOL
61:205-208 |
1999 |
48 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION
95:809-813 |
1997 |
49 YRS |
F |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION
95:809-813 |
1997 |
83 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION
96:3809-3810 |
1997 |
NA |
M |
NA |
No |
NA |
Excluded |
1 |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION
96:3809-3810 |
1997 |
NA |
M |
NA |
No |
NA |
Excluded |
1 |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION 96:3809-3810 |
1997 |
NA |
F |
NA |
No |
NA |
Excluded |
1 |
|
ABCIXIMAB c7E3 FAB |
CLIN CARDIOL
21:851-852 |
1998 |
82 YRS |
M |
No |
Yes |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
LANCET 352:1312 |
1998 |
63 YRS |
M |
No |
Yes |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
HAEMATOLOGICA 86:E07 |
2001 |
82 YRS |
M |
NO |
Yes |
0 |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
J AM COLL CARDIOL
32:311-319 |
1998 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION
95:809-813 |
1997 |
62 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J HEMATOL
61:205-208 |
1999 |
51 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J HEMATOL
61:205-208 |
1999 |
55 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL
78:1161-1163 |
1996 |
42 YRS |
M |
NA |
Yes |
2 |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL
78:1161-1163 |
1996 |
59 YRS |
F |
NA |
Yes |
3 |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL
78:1161-1163 |
1996 |
64 YRS |
M |
NA |
Yes |
3 |
2 |
NA |
|
ABCIXIMAB c7E3 FAB |
AM J CARDIOL
78:1161-1163 |
1996 |
70 YRS |
M |
NA |
Yes |
2 |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
J INVASIVE CARDIOL
12:109-112 |
2000 |
52 YRS |
M |
NO |
Yes |
0 |
2 |
NA |
|
ABCIXIMAB c7E3 FAB |
J INVASIVE CARDIOL
11:313-315 |
1999 |
75 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION 97:1214-1215 |
1998 |
62 YRS |
M |
No |
Yes |
NA |
3 |
NA |
|
ABCIXIMAB c7E3 FAB |
CIRCULATION
95:809-813 |
1997 |
53 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ACETAMINOPHEN |
NEJM 287:376-381 |
1972 |
22 YRS |
M |
NA |
Yes |
NA |
3 |
NA |
|
ACETAMINOPHEN |
CLEVELAND CLINIC 40:
89-91 |
1973 |
61 YRS |
M |
No |
Yes |
3 |
2 |
NA |
|
ACETAMINOPHEN |
NEJM 300:678 |
1979 |
29 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ACETAMINOPHEN |
BMJ 3:743-374 |
1968 |
63 YRS |
F |
No |
No |
1 |
1 |
NA |
|
ACETAMINOPHEN |
LANCET 2:1159 |
1978 |
30 YRS |
M |
No |
Yes |
2 |
1 |
NA |
|
ACETAMINOPHEN |
ANN INTERN MED 95:783 |
1981 |
80 YRS |
M |
No |
Yes |
3 |
2 |
NA |
|
ACETAMINOPHEN |
NEJM 303:47 |
1980 |
70 YRS |
M |
No |
No |
1 |
1 |
NA |
|
ACETAMINOPHEN |
BLOOD 97:3846 |
2001 |
66 YRS |
F |
NA |
No |
NA |
2 |
NA |
|
ACETAMINOPHEN |
BLOOD 97:3846 |
2001 |
30 YRS |
M |
NA |
No |
NA |
2 |
NA |
|
ACETAZOLAMIDE |
AM J OPHTHALMOL
100:79-81 |
1985 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ACETAZOLAMIDE |
JAMA 160:206-207 |
1956 |
85 YRS |
M |
No |
Yes |
3 |
2 |
NA |
|
ACETAZOLAMIDE |
ARCH INTERN MED
99:1006 |
1957 |
61 YRS |
M |
No |
No |
NA |
2 |
NA |
|
ACETAZOLAMIDE |
ARCH INTERN MED
99:1000 |
1957 |
61 YRS |
M |
NA |
Yes |
NA |
4 |
NA |
|
ACYCLOVIR |
AM J EMER MED
16:396-398 |
1998 |
8 YRS |
M |
NA |
No |
NA |
Excluded |
2,6 |
|
ADRENOCORTICOSTEROID |
PACIFIC MED SURG 75:33-34 |
1967 |
2 YRS |
M |
NA |
No |
NA |
Excluded |
1,6 |
|
ALATROFLOXACIN |
ANN PHARMACOTHER
34:330 |
2000 |
54 YRS |
F |
NO |
Yes |
2 |
2 |
NA |
|
ALBENDAZOLE |
ANN PHARMACOTHER
32:842 |
1998 |
25 YRS |
F |
No |
Yes |
2 |
2 |
NA |
|
ALLOPURINOL |
JAMA 227:1036 |
1974 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ALLOPURINOL |
MED J AUST 2:468 |
1973 |
86 YRS |
F |
NA |
No |
NA |
Excluded |
1 |
|
ALLOPURINOL |
DICP 15:286-287 |
1981 |
NA |
NA |
NA |
No |
NA |
Excluded |
2 |
|
ALLYLISOPROPYLACETYLUREA |
AM J MED 14:605 |
1953 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ALPRENOLOL |
ACTA MED SCAND
207:231-233 |
1980 |
65 YRS |
F |
No |
Yes |
2 |
1 |
NA |
|
AMINOGLUTETHIMIDE |
CANCER TREATMENT
REPORTS 68:1015-1016 |
1984 |
53 YRS |
F |
No |
Yes |
3 |
1 |
NA |
|
AMINOGLUTETHIMIDE |
TUMORI 76:511-512 |
1990 |
49 YRS |
F |
NA |
Yes |
NA |
3 |
NA |
|
AMINOGLUTETHIMIDE |
CANCER TREATMENT
REPORTS 66:1785-1786 |
1982 |
58 YRS |
F |
No |
Yes |
0 |
1 |
NA |
|
AMINOGLUTETHIMIDE |
CANCER TREATMENT
REPORTS 67:849 |
1983 |
47 YRS |
F |
NA |
Yes |
NA |
4 |
NA |
|
AMINOGLUTETHIMIDE |
CONN MED 48:423-424 |
1984 |
63 YRS |
F |
No |
No |
2 |
2 |
NA |
|
AMINOSALICYLIC ACID |
J CLIN GASTROENTEROL
22:160-161 |
1996 |
36 YRS |
F |
NA |
No |
NA |
Excluded |
2 |
|
AMINOSALICYLIC ACID |
AM J MED 53:790-796 |
1972 |
45 YRS |
M |
No |
Yes |
1 |
2 |
NA |
|
AMINOSALICYLIC ACID |
JAMA 153:1094 |
1953 |
18 YRS |
F |
No |
No |
3 |
1 |
NA |
|
AMINOSALICYLIC ACID |
JAMA 172:1909 |
1960 |
63 YRS |
M |
No |
Yes |
2 |
1 |
NA |
|
AMIODARONE |
ARCH INTERN MED
147:735-736 |
1987 |
69 YRS |
M |
No |
Yes |
1 |
1 |
NA |
|
AMIODARONE |
ARCH INTERN MED
147:735-736 |
1987 |
45 YRS |
M |
No |
Yes |
1 |
1 |
NA |
|
AMITRIPTYLINE |
AM J HEMATOL 53:49-50 |
1996 |
68 YRS |
F |
NA |
No |
NA |
3 |
NA |
|
AMLODIPINE |
ANN PHARMACOTHER
33:1126 |
1999 |
34 YRS |
F |
No |
No |
3 |
2 |
NA |
|
AMPHOTERACIN B |
JAPI 38:235-236 |
1990 |
37 YRS |
M |
No |
Yes |
0 |
1 |
NA |
|
AMPHOTERACIN B |
ANN INTERN MED
96:332-333 |
1982 |
48 YRS |
M |
No |
Yes |
0 |
1 |
NA |
|
AMPHOTERACIN B |
JAPI 38:235-236 |
1990 |
20 YRS |
M |
No |
Yes |
0 |
2 |
NA |
|
AMPICILLIN |
MED J AUST 1:435 |
1972 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
AMPICILLIN |
ACTA HAEMATOL 67:71 |
1982 |
80 YRS |
F |
NA |
No |
NA |
4 |
NA |
|
AMPICILLIN |
LANCET 2:723 |
1974 |
69 YRS |
F |
No |
Yes |
3 |
2 |
NA |
|
AMPICILLIN |
ANN INTERN MED 99:573 |
1983 |
30 YRS |
F |
No |
Yes |
2 |
2 |
NA |
|
AMRINONE |
NEJM 301:1185 |
1979 |
63 YRS |
M |
NA |
Yes |
NA |
Excluded |
1 |
|
AMRINONE |
SCAND J HAEMATOL
31:376 |
1983 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
AMRINONE |
ARCH INTERN MED
144:949-952 |
1984 |
NA |
NA |
No |
No |
0 |
1 |
NA |
|
ANAGRELIDE |
PHARMACOTHER
18:822-826 |
1997 |
43 YRS |
F |
No |
Yes |
NA |
Excluded |
3 |
|
ANAGRELIDE |
BLOOD 79:1931-1937 |
1992 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ANAGRELIDE |
AM J HEALTH SYST
PHARM 55:1979-1986 |
1998 |
NA |
NA |
NA |
No |
NA |
Excluded |
1,3 |
|
ANTILIPEMIC AGENTS |
MAYO CLIN PROC
67:465-468 |
1992 |
62 YRS |
F |
NA |
No |
NA |
Excluded |
2 |
|
ANTILIPEMIC AGENTS |
MAYO CLIN PROC
67:465-468 |
1992 |
51 YRS |
M |
NA |
No |
NA |
Excluded |
1 |
|
ANTILIPEMIC AGENTS |
MAYO CLIN PROC
67:465-468 |
1992 |
66 YRS |
F |
NA |
No |
NA |
Excluded |
2 |
|
APALCILLIN |
UROL INT 42:313-315 |
1987 |
60 YRS |
F |
No |
Yes |
2 |
2 |
NA |
|
ARSPHENAMINE |
ARCH INTERN MED
5:1238 |
1932 |
34 YRS |
M |
NA |
Yes |
NA |
Excluded |
4 |
|
ASPIRIN |
NEJM 300:678 |
1979 |
29 YRS |
M |
NA |
No |
NA |
3 |
NA |
|
ASPIRIN |
BR J PHARMACOL
60:292-293 |
1977 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
ASPIRIN |
AM J MED SCI
267:129-132 |
1974 |
75 YRS |
M |
No |
Yes |
1 |
2 |
NA |
|
ATORVASTATIN |
LANCET 352:1284 |
1998 |
46 YRS |
M |
No |
Yes |
1 |
1 |
NA |
|
BENZODIAZEPINES |
ACTA HAEMATOL 68:68 |
1982 |
15 YRS |
M |
NA |
No |
NA |
Excluded |
6 |
|
BENZTROPINE MESYLATE |
PSYCHOSOMATICS 41:277 |
2000 |
38 YRS |
F |
NO |
Yes |
0 |
4 |
NA |
|
BISMUTH |
GUT 30:1016 |
1989 |
72 YRS |
M |
No |
Yes |
2 |
2 |
NA |
|
BLEOMYCIN |
EUR J CANCER
14:1261-1264 |
1978 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
BLEOMYCIN |
EUR J CANCER 19:867 |
1983 |
NA |
NA |
NA |
No |
NA |
Excluded |
3 |
|
BLEOMYCIN |
EUR J CANCER
14:1261-1264 |
1978 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
BLEOMYCIN |
EUR J CANCER
14:1261-1264 |
1978 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
BLEOMYCIN |
EUR J CANCER 14:1261-1264 |
1978 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
BLEOMYCIN |
NETH J MED 27:202 |
1984 |
NA |
NA |
NA |
No |
NA |
Excluded |
3 |
|
BLEOMYCIN |
EUR J CANCER
14:1261-1264 |
1978 |
NA |
NA |
NA |
No |
NA |
3 |
NA |
|
BROMOCRIPTINE |
AM J MED SCI
281:169-172 |
1981 |
NA |
NA |
NA |
No |
NA |
Excluded |
2 |
|
BUMETANIDE |
POSTGRAD MED J 51:51-52 |
1975 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
BUTABARBITAL |
BMJ 2:919 |
1957 |
65 YRS |
M |
NA |
Yes |
NA |
3 |
NA |
|
BUTOCONAZOLE |
DICP 24:143-144 |
1990 |
54 YRS |
F |
No |
Yes |
3 |
2 |
NA |
|
CAPTOPRIL |
SINGAPORE MED J
29:526-527 |
1988 |
62 YRS |
M |
NA |
Yes |
NA |
Excluded |
1,5 |
|
CAPTOPRIL |
IR MED J 80:101 |
1987 |
70 YRS |
M |
No |
Yes |
0 |
2 |
NA |
|
CAPTOPRIL |
IR MED J 79:43-44 |
1986 |
68 YRS |
M |
NA |
Yes |
NA |
3 |
NA |
|
CAPTOPRIL |
VOX SANG 57:218 |
1989 |
NA |
NA |
NA |
No |
NA |
Excluded |
1 |
|
CAPTOPRIL |
BMJ 298:189-190 |
1989 |
75 YRS |
F |
No |
Yes |
1 |
2 |
NA |
|
CARBAMEZAPINE |
PSYCHIATRY CLIN
NEUROSCI 55:423 |
2001 |
67 YRS |
F |
NO |
Yes |
0 |
3 |
NA |
|
CARBAMEZAPINE |
ACTA HAEMATOL 68:74 |
1982 |
31 YRS |
F |
No |
Yes |
1 |
2 |
NA |
|
CARBAMEZAPINE |
AM J MED SCI
262:68-78 |
1971 |
49 YRS |
F |
NA |
No |
NA |
2 |
NA |
|
CARBAMEZAPINE |
J CLIN PSYCHIATRY
53:378 |
1992 |
40 YRS |
F |
No |
No |
1 |
2 |
NA |
|
CARBAMEZAPINE |
J CLIN PSYCHIATRY
52:496-498 |
1991 |
18 YRS |
F |
NA |
Yes |
NA |
3 |
NA |
|
CARBAMEZAPINE |
AM J EMER MED
16:396-398 |
1998 |
8 YRS |
M |
NA |
No |
NA |
Excluded |
2,5,6 |
|
CARBAMEZAPINE |
VOX SANG 65:328-330 |
1993 |
38 YRS |
F |
NA |
No |
NA |
3 |
NA |
|
CARBAMEZAPINE |
LANCET 7:223 |
1968 |
79 YRS |
F |
NO |
Yes |
0 |
2 |
NA |
|
CARBAMEZAPINE |
J CLIN PSYCHIATRY 45:315-316 |
1984 |
66 YRS |
F |
No |
Yes |
1 |
2 |
NA |
|
CARBAMEZAPINE |
DICP 17:642-644 |
1983 |
33 YRS |
F |
NA |
Yes |
NA |
3 |
NA |
|
CARBAMEZAPINE |
CLIN PHARM 4:221-223 |
1985 |
4 YRS |
F |
NO |
Yes |
0 |
Excluded |
6 |
|
CARBAMEZAPINE |
EURO J PEDIATR
152:769-770 |
1993 |
10 YRS |